市場調查報告書

連網型注射藥物輸送設備市場預測:傳統設備·自我注射型設備·其他

Connected Injectable Drug Delivery Devices Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 622669
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
連網型注射藥物輸送設備市場預測:傳統設備·自我注射型設備·其他 Connected Injectable Drug Delivery Devices Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 112 Pages
簡介

本報告提供全球連網型注射藥物輸送設備的市場調查,提供市場定義和概要,競爭環境與市場佔有率,市場的各種影響因素及市場機會分析,價值鏈,產品生命週期分析,設備類型·技術·用途·終端用戶·地區/各主要國家趨勢與市場規模的變化與預測,並彙整主要企業簡介等資訊。

第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 競爭經營者分析
    • 產品基準
    • 終端用戶的簡介
    • 前五名公司的財務分析
    • 專利分析

第4章 市場影響因素

  • 成長推進因素
  • 阻礙成長要素·課題
  • 波特的五力分析

第5章 策略性市場分析

  • 價值鏈分析
  • 價格分析
  • 市場機會分析
  • 產品·市場生命週期

第6章 市場分析·預測:不同設備類型

  • 簡介
  • 吸入器
  • 注射器
    • 手持設備
    • 穿戴式設備
  • 固態劑型
  • 其他

第7章 市場分析·預測:各技術

  • 簡介
  • Bluetooth
  • 智慧型手機應用程式
  • NFC
  • 緊急技術

第8章 市場分析·預測:各用途

  • 簡介
  • 糖尿病
  • 心血管疾病
  • 自體免疫疾病
  • 荷爾蒙補充
  • 神經科
  • 呼吸系統疾病
  • 其他

第9章 市場分析·預測:各終端用戶

  • 簡介
  • 醫院
  • 診療所
  • 居家照護

第10章 市場分析·預測:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲&紐西蘭
    • 其他
  • 其他地區
    • 南美
    • 中東
    • 非洲

第11章 市場熵

  • 擴張
  • 技術開發
  • M&A·JV
  • 供給契約

第12章 企業簡介

  • Phillips-Medisize Corporation
  • West Pharmaceutical Services, Inc.
  • Biocorp
  • Aterica, Inc.
  • Unilife Corporation
  • Panasonic
  • Propeller Health
  • Qualcomm Technologies, Inc.
  • Haselmeier
  • SHL Group

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 1211

Connected Injectable Drug Delivery Devices Market Overview

Self-administration of drugs through pre-filled syringes is one of the different ways that is helping patients save the fees given to a caregiver. The global connected injectable drug delivery devices market is estimated to surpass $22,814m by 2023, growing at an estimated CAGR of 6.8% from 2018 to 2023.The Europe region is the largest market for connected injectable drug delivery devices owing to the large customer pool.

Connected Injectable Drug Delivery Devices Market Outlook

Connected injectable drug delivery devices record the dosing pattern of patients and makes it available to healthcare professionals. These drug delivery devices help in addressing patient's issues with regard to medications, treatments, and disease management protocols that are of major concern for professionals in the healthcare and pharmaceutical industries. Before bringing a connected health offering to life, it is important to understand the fundamentals of patient-centric design. One of the most successful elements in fulfilling the need for patient-centric design is human factors analysis, which benefits the patient by making injection systems more comfortable and user-friendly.

This report provides an in-depth analysis of the connected injectable drug delivery devices market by delivery devices type, connectivity technology, by disease, and by geography. On the basis of delivery devices type, the market is categorized into conventional injection devices, self-injection devices, and others. On the basis of connectivity technology, the market is segmented into wireless technology, Bluetooth, near infrared technology, and smart phone apps. Based on disease, the market is categorized into anaphylaxis, autoimmune disease, cardiovascular, diabetes, hormone replacement, and others.

Connected Injectable Drug Delivery Devices Market Growth Drivers

The market is forecast to be majorly driven by the increase in cases of chronic diseases like rheumatoid arthritis, cardiovascular disease, cancer and diabetes. The increasing concern of the pharmaceutical or medical devices companies towards development of connected injectable drug delivery devices is expected to drive the connected injectable drug delivery devices market.

Connected Injectable Drug Delivery Devices Market Challenges

The regulatory hurdles due to high requirement of data and evidences for developing new technologies and recent product recalls by the FDA are restraining the growth of the connected injectable drug delivery devices market. High cost of these connected injectable drug delivery devices and data security and privacy issues are also hindering the market growth.

Connected Injectable Drug Delivery Devices Market Research Scope

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the connected injectable drug delivery devices market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to measure their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of delivery devices, and connectivity technology in the connected injectable drug delivery devices market.

Connected Injectable Drug Delivery Devices Market Report: Industry Coverage

Delivery devices type in Connected Injectable Drug Delivery Devices: Conventional Injection Devices, Self-Injection Devices, and Others

Connectivity technology in Connected Injectable Drug Delivery Devices: Wireless Technology, Bluetooth, Near Field Technology, and Smart Phone Apps

Diseases in Connected Injectable Drug Delivery Devices: Anaphylaxis, Autoimmune Disease, Cardiovascular, Diabetes, Hormone Replacement, and Others

The Connected Injectable Drug Delivery Devices Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

The Middle East and Africa: Israel, South Africa, Saudi Arabia

Connected Injectable Drug Delivery Devices Market Key Players Perspective

Some of the key players mentioned in this report are Ypsomed Holdings, Unolife Corporation, Quio Technologies, SHL Group, Biocorp, Haselmeier Inc., and West Pharmaceutical Services, Inc.

Connected Injectable Drug Delivery Devices Market Trends

Rising prevalence of multiple sclerosis and rheumatoid arthritis will also impact the connected injectable drug delivery devices market.

Rising incidence of diabetes globally will also propel the growth of the connected injectable drug delivery devices market

Conventional injection devices accounted for the major share of the total market in 2017.

As per IndustryARC analysis, the conventional injection devices segment will generate substantial revenue by 2023. The advancement in technology and rising incidences of rheumatoid arthritis and multiple sclerosis are set to drive the market in the next few years.

1. Connected Injectable Drug Delivery Devices Market - Overview

  • 1.1. Definitions and Scope

2. Connected Injectable Drug Delivery Devices Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Connected Injectable Drug Delivery Devices Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 8 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 8 companies
    • 3.1.4. Patent Analysis - Top 8 companies
    • 3.1.5. Pricing Analysis

4. Connected Injectable Drug Delivery Devices Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Connected Injectable Drug Delivery Devices Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle
  • 5.4. Suppliers and distributors Market Share

6. Connected Injectable Drug Delivery Devices Market - By Delivery Devices Type (Market Size -$Million / $Billion)

  • 6.1. Market Size and Market Share Analysis
  • 6.2. Application Revenue and Trend Research
  • 6.3. Product Segment Analysis
    • 6.3.1. Conventional Injection Devices
    • 6.3.2. Self-Injection Devices
      • 6.3.2.1. Pen Injectors
      • 6.3.2.2. Needle Free Injectors
      • 6.3.2.3. Auto Injectors
    • 6.3.3. Others

7. Connected Injectable Drug Delivery Devices Market - By Connectivity Technology (Market Size -$Million / $Billion)

  • 7.1. Introduction
  • 7.2. Wireless Technology
  • 7.3. Bluetooth
  • 7.4. Near Field Technology
  • 7.5. Smart Phone Apps

8. Connected Injectable Drug Delivery Devices Market - By Disease (Market Size -$Million / $Billion)

  • 8.1. Introduction
  • 8.2. Anaphylaxis
  • 8.3. Autoimmune Disease
  • 8.4. Cardiovascular
  • 8.5. Diabetes
  • 8.6. Hormone Replacement
  • 8.7. Others

9. Connected Injectable Drug Delivery Devices - By Geography (Market Size -$Million / $Billion)

  • 9.1. Connected Injectable Drug Delivery Devices Market - North America Segment Research
  • 9.2. North America Market Research (Million / $Billion)
    • 9.2.1. Segment type Size and Market Size Analysis
    • 9.2.2. Revenue and Trends
    • 9.2.3. Application Revenue and Trends by type of Application
    • 9.2.4. Company Revenue and Product Analysis
    • 9.2.5. North America Product type and Application Market Size
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
      • 9.2.5.4. Rest of North America
  • 9.3. Connected Injectable Drug Delivery Devices - South America Segment Research
  • 9.4. South America Market Research (Market Size -$Million / $Billion)
    • 9.4.1. Segment type Size and Market Size Analysis
    • 9.4.2. Revenue and Trends
    • 9.4.3. Application Revenue and Trends by type of Application
    • 9.4.4. Company Revenue and Product Analysis
    • 9.4.5. South America Product type and Application Market Size
      • 9.4.5.1. Brazil
      • 9.4.5.2. Venezuela
      • 9.4.5.3. Argentina
      • 9.4.5.4. Ecuador
      • 9.4.5.5. Peru
      • 9.4.5.6. Colombia
      • 9.4.5.7. Costa Rica
      • 9.4.5.8. Rest of South America
  • 9.5. Connected Injectable Drug Delivery Devices - Europe Segment Research
  • 9.6. Europe Market Research (Market Size -$Million / $Billion)
    • 9.6.1. Segment type Size and Market Size Analysis
    • 9.6.2. Revenue and Trends
    • 9.6.3. Application Revenue and Trends by type of Application
    • 9.6.4. Company Revenue and Product Analysis
    • 9.6.5. Europe Segment Product type and Application Market Size
      • 9.6.5.1. U.K
      • 9.6.5.2. Germany
      • 9.6.5.3. Italy
      • 9.6.5.4. France
      • 9.6.5.5. Netherlands
      • 9.6.5.6. Belgium
      • 9.6.5.7. Spain
      • 9.6.5.8. Denmark
      • 9.6.5.9. Rest of Europe
  • 9.7. Connected Injectable Drug Delivery Devices - APAC Segment Research
  • 9.8. APAC Market Research (Market Size -$Million / $Billion)
    • 9.8.1. Segment type Size and Market Size Analysis
    • 9.8.2. Revenue and Trends
    • 9.8.3. Application Revenue and Trends by type of Application
    • 9.8.4. Company Revenue and Product Analysis
    • 9.8.5. APAC Segment - Product type and Application Market Size
      • 9.8.5.1. China
      • 9.8.5.2. Australia
      • 9.8.5.3. Japan
      • 9.8.5.4. South Korea
      • 9.8.5.5. India
      • 9.8.5.6. Taiwan
      • 9.8.5.7. Malaysia

10. Connected Injectable Drug Delivery Devices Market - Entropy

  • 10.1. New product launches
  • 10.2. M&A's, collaborations, JVs and partnerships

11. Connected Injectable Drug Delivery Devices Market Company Analysis

  • 11.1. Market Share, Company Revenue, Products, M&A, Developments
  • 11.2. Ypsomed Holdings
  • 11.3. Unolife Corporation
  • 11.4. Quio Technologies
  • 11.5. SHL Group
  • 11.6. Biocorp
  • 11.7. Haselmeier Inc.
  • 11.8. West Pharmaceutical Services Inc.
  • 11.9. Company 8
  • 11.10. Company 9
  • 11.11. Company 10 and more

"*Financials would be provided on a best efforts basis for private companies"

12. Connected Injectable Drug Delivery Devices Market -Appendix

  • 12.1. Abbreviations
  • 12.2. Sources